Chronic Kidney Disease Stage 4
Understanding Chronic Kidney Disease Stage 4 (CKD Stage IV) is crucial for accurate clinical documentation and medical coding. This resource provides information on CKD Stage 4, including diagnosis criteria, treatment options, and managing Chronic Renal Failure Stage 4. Learn about GFR ranges, symptoms, and complications associated with Chronic Kidney Disease Roman Numeral 4 for improved healthcare outcomes. This guide also addresses Chronic Kidney Disease stage 4 ICD-10 codes and other relevant medical coding terminology.
Severe decrease in kidney function (GFR 15-29 mL/min) causing waste buildup in the body.
Swelling, fatigue, nausea, loss of appetite, changes in urination, high blood pressure.
Nephrology clinics, dialysis centers, primary care offices, hospitals.
ICD-10 Code Families
Complete code families applicable to N18.4
When to use each related code
| Description | When to use |
|---|---|
| Severe kidney damage with reduced GFR (15-29 mL/min) | Confirmed GFR 15-29 mL/min/1.73 m2 for 3+ months. Document cause and complications. |
| Moderately reduced kidney function (GFR 30-59 mL/min) | Confirmed GFR 30-59 mL/min/1.73 m2 for 3+ months. Specify cause if known. |
| Mildly reduced kidney function (GFR 60-89 mL/min) | Confirmed GFR 60-89 mL/min/1.73 m2 for 3+ months. Often asymptomatic. |
Best-practice checklist
- ✓CKD Stage 4 diagnosis: Document GFR and albuminuria.
- ✓CKD Stage IV: Specify cause and comorbidities.
- ✓Chronic Renal Failure Stage 4: Note treatment plan.
- ✓Document complications (e.g., anemia, bone disease).
- ✓CKD IV coding: Use ICD-10-CM N18.4
Common pitfalls to avoid
Insufficient documentation to support stage 4 specifically. Coding requires lab results and clinical findings.
Missing codes for associated hypertension, diabetes, or other contributing conditions impacting DRG assignment.
Unspecified laterality for kidney involvement if applicable. Documentation must clarify unilateral/bilateral disease.
Best-practice tips
- 01Code CKD Stage 4 with ICD-10-CM G5.4. Document disease severity.
- 02For CKD Stage 4, specify GFR and albuminuria for accurate coding.
- 03Ensure CKD stage progression is clearly documented for compliant billing.
- 04Query physician for clarification if CKD documentation is unclear.
- 05Regularly review CKD coding guidelines for optimal reimbursement.
Step-by-step checklist
- 1
Verify eGFR 15-29 mL/min/1.73 m2 for 3+ months (ICD-10 N18.4)
- 2
Confirm persistent albuminuria (ICD-10 N04.x)
- 3
Document CKD complications (anemia, bone disease)
- 4
Review medications impacting renal function
- 5
Patient education on CKD stage 4 management
Ready-to-paste narrative
Patient presents with chronic kidney disease stage 4 (CKD stage IV, chronic renal failure stage 4), confirmed by estimated glomerular filtration rate (eGFR) between 15 and 29 mL/min/1.73 m2 and persistent albuminuria. Relevant lab values include elevated serum creatinine and blood urea nitrogen (BUN). Patient reports symptoms consistent with CKD stage 4, including fatigue, swelling in the legs and feet, decreased urine output, loss of appetite, nausea, and difficulty sleeping. Medical history includes hypertension, managed with [medication name(s) and dosage(s)], and [mention any other relevant comorbidities, e.g., diabetes, cardiovascular disease]. Assessment indicates progression from previous stage 3 chronic kidney disease. The patient's current medication regimen was reviewed and adjusted as needed to optimize blood pressure control and mitigate CKD progression. Patient education provided on dietary restrictions, including protein restriction and potassium management, fluid intake guidelines, and the importance of medication adherence. Referral initiated to a nephrologist for further evaluation and management of CKD stage 4, including discussion of renal replacement therapy options such as dialysis or kidney transplant. Follow-up appointment scheduled in [timeframe] to monitor kidney function, electrolyte balance, and overall clinical status. ICD-10 code N18.4 assigned.
Common questions and answers
What are the key differentiating factors in chronic kidney disease stage 4 management compared to earlier stages, and how can clinicians optimize patient outcomes in this advanced stage?+
Chronic kidney disease stage 4 management requires a more intensive approach compared to earlier stages due to the significant decline in kidney function (estimated glomerular filtration rate [eGFR] between 15-29 mL/min/1.73 m2). Key differentiating factors include closer monitoring of electrolyte imbalances (especially potassium and phosphorus), more aggressive management of hypertension and anemia, and detailed patient education regarding renal replacement therapy options (dialysis or transplantation). Optimizing patient outcomes in this advanced stage necessitates a multidisciplinary approach involving nephrologists, dietitians, social workers, and other healthcare professionals. Consider implementing a comprehensive care plan addressing medication management, dietary restrictions (protein, phosphorus, potassium), anemia management with erythropoiesis-stimulating agents (ESAs), and proactive planning for dialysis access or transplantation. Explore how early integration of palliative care can improve quality of life for patients with stage 4 CKD.
How do I effectively communicate the prognosis and treatment options for chronic kidney disease stage 4 with patients and their families, addressing their emotional and psychological needs?+
Communicating the prognosis and treatment options for chronic kidney disease stage 4 requires empathy, clarity, and a patient-centered approach. Start by assessing the patient's and family's understanding of CKD and their emotional preparedness for this information. Clearly explain the progressive nature of the disease and the implications of stage 4, including the eventual need for renal replacement therapy. Openly discuss the various treatment options, including hemodialysis, peritoneal dialysis, and kidney transplantation, highlighting the benefits and drawbacks of each. Acknowledge the emotional and psychological impact of this diagnosis, offering resources such as support groups, mental health professionals, and palliative care services. Learn more about effective communication strategies for delivering difficult news and supporting patients through advanced chronic illness. Encourage patients to actively participate in shared decision-making regarding their care.
What are the latest clinical guidelines for managing complications associated with chronic kidney disease stage 4, such as mineral and bone disorders, cardiovascular disease, and anemia?+
Managing complications associated with chronic kidney disease stage 4 requires adherence to the latest clinical guidelines, such as those published by the Kidney Disease Improving Global Outcomes (KDIGO) and the National Kidney Foundation (NKF). Mineral and bone disorders (MBD) should be addressed through phosphate binders, vitamin D analogs, and calcimimetics to control hyperphosphatemia, secondary hyperparathyroidism, and abnormal bone metabolism. Cardiovascular disease (CVD) risk reduction strategies include aggressive blood pressure control, lipid-lowering therapy, and lifestyle modifications. Anemia management involves iron supplementation and erythropoiesis-stimulating agents (ESAs), with careful monitoring of hemoglobin levels and iron stores. Explore how the latest KDIGO guidelines recommend individualizing treatment targets based on patient comorbidities and preferences. Consider implementing a structured approach to CKD-MBD and CVD management to optimize patient outcomes in stage 4 CKD.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.